Stocks To Buy Now Blog

Stocks on Radar

On the Move Systems, Inc. (OMVS) Reaffirms Optimism in Shared Economy Model

On the Move Systems, focused on the development of various technologies across a wide range of industries, today said one industry analyst’s bold prediction on how the continued rise of 3D printing will alter the freight business in OMVS’s favor reaffirms the company’s bullish stance for the long-term growth prospects for its “Uber-for-Trucking” shared economy platform.

The trucking analyst noted that 3D printing’s rapid climb will enable manufacturers to source more of their materials closer to the factory, thus making national truckers more dependent on local freight networks to deliver materials. To thrive in this coming era, the pundit continued, long-haul carriers will need to build and strengthen their networks with smaller, independent truckers.

This prediction holds great promise for OMVS, which is currently building a revolutionary shared economy business model that will enable these national trucking firms to do exactly that, both online and on demand.

Today’s trucking companies rely on technology to maximize profit from their vehicles, and OMVS’s upcoming platform will enable truckers to not only build networks, but maximize equipment utilization, recruit drivers, and effectively price their services.

“It’s a daring prediction, and one that plays directly into our long-term research and due diligence,” OMVS CEO and President Robert Wilson stated in the news release. “Our revolutionary Uber-for-Trucking platform can help long-haul carriers in building their local networks, and aid local truckers in strengthening ties to long-haul carriers wanting access to their market. Those using our service will be in a great position to succeed when this forecast comes to pass. And OMVS will be in a great position to benefit from strong revenues from these users.”

For more information, visit www.onthemovesystems.com

Let us hear your thoughts: On the Move Systems Corp. Message Board

Content Checked Holdings, Inc. (CNCK) Providing Mobile Solution to Navigating Potentially Dangerous Food Allergies

Content Checked Holdings, Inc. (OTCQB: CNCK) caters to the underserved marketplace for people with dietary restrictions and its associated organizations through the continued development and commercialization of the ContentChecked, MigraineChecked and SugarChecked smartphone applications. The company’s innovative apps, which are currently available on both Google Play and the Apple App Store, allow users to scan food products for food allergens and other unwanted ingredients and provides recommendations of alternative products and recipes that fit within the user’s dietary preferences.

“Born from a father’s confusion and frustration about what to feed his daughter and her friends with specific food allergies, Content Checked was founded to design and develop solutions that will positively impact individuals’ health,” Kris Finstad, chief executive officer of Content Checked, stated in a news release. “[W]e see ContentChecked as being a critical tool to newly diagnosed food allergy families just learning to read labels and finding safe foods.”

In recent years, the prevalence of potentially life-threatening food allergies has rapidly increased. According to data from the Centers for Disease Control and Prevention, the occurrence of food allergies and associated anaphylaxis increased by 18 percent between 1997 and 2007. Today, an estimated 12 million Americans suffer from food allergies, including eight percent of all children, based on a study by the Food Allergy Initiative. For Content Checked, these statistics highlight the potentially massive market appeal of its groundbreaking suite of apps moving forward.

Since being founded in 2013, Content Checked has developed a robust database of allergens, migraine triggers and food ingredients that directly correlate with food allergies or other potential health concerns, which forms the basis of its proprietary apps. This database currently features hundreds of thousands of products, and its highly scalable design will allow the company to expand its services into potentially lucrative markets around the country with limited modifications and investment.

In April, Content Checked prepared to build upon the early progress of its product suite by officially going public. This move allowed the company to secure $1.9 million in funding for the continued development and promotion of its apps. In June, Content Checked gave individual investors improved access to trade shares of the company by listing on the OTCQB exchange.

“Meeting the increased compliance and information requirements of OTCQB provides our investors greater confidence in the information disclosed by the company and ensures our commitment to accountability and transparency,” continued Finstad. “We will continue working toward our goals of uplisting in the future to the NASDAQ stock market and growing our business.”

For prospective shareholders, Content Checked represents an opportunity to invest in an early-stage company with near limitless growth potential as the company continues to scale its databases to increase the market appeal of its app suite across the country.

For more information, visit www.contentchecked.com

Aristocrat Group Corp. (ASCC) Announces Plans to Promote Flagship Brand at ‘World’s Premiere Cocktail Festival’

Today before the opening bell, the Aristocrat Group announced that it plans on promoting its flagship brand in New Orleans at what’s being publicized as the world’s premiere cocktail festival.

Named “Tales of the Cocktail,” this five-day event in July is full of seminars, tastings, networking and promotion that bring together the international spirits industry to examine top trends and the future of the business. For the first time, RWB Vodka will have its own booth at the festival, exposing the made-in-the-U.S.A. vodka to vendors, distributors and bartenders from around the country and beyond.

“We’re thrilled to be a part of such a large and prestigious gathering, which will be the focus of the entire spirits industry for five days,” stated ASCC CEO Robert Federowicz. “This will be an especially significant event for our company as we work to secure distribution for RWB Vodka in the state of Louisiana.”

ASCC has enjoyed consistent growth since the debut of its flagship product. Following a dedicated, nationwide marketing push that has included tasting tours, sports sponsorships and artist endorsements, the company has built considerable momentum heading into the summer. In April, the company celebrated a new all-time high in total sales of RWB Vodka, and expects the numbers for May to be even better once they’re released.

RWB Handcrafted Ultra-Premium Vodka is currently available at hundreds of retail locations and online, with talks underway to make the brand available in Canada and Mexico. Soon, the company plans to boost its business dramatically by unveiling a new brand this year poised to offer consumers an unprecedented level of convenience—creating a whole new market segment in the process.

For more information on the company, visit www.aristocratgroupcorp.com/investors

Let us hear your thoughts: The Aristocrat Group Corp. Message Board

Feel Empowered to Make that Trade with TradePower.com

Purchasing stock confidently requires the right knowledge. As Francis Bacon, the father of the scientific method once stated, “Knowledge is power.”

In mankind’s agricultural past, ownership of land and property meant power. During the Industrial Revolution, ownership of factories and machinery became the basis of wealth and power. Now more than ever, in our globally integrated cybernetic information driven world, knowledge and information in and of itself has become the basis of wealth and power. Examples of those that are powerful due to our current knowledge based society include the wealth of Bill Gates to the influence of the large pharmaceutical companies of which both are based on intellectual property rights.

Control of information is something corporate elites always recognized as a way to consolidate and build wealth and power. In 1983, 90% of American media was owned by 50 companies. Right now, over 90% of the information diet of 313 million Americans is controlled by 6 corporations: News Corporation, Disney, Comcast, Viacom, Time Warner, and CBS. That is 90% of everything Americans see, hear, and consider important. As author Tom Clancy pointed out, those that control the information can control the people. Governments that are despotic have long recognized the importance of controlling the flow of information in a society. For example, China’s government controls its population in part by maintaining massive surveillance and a content control system over their population’s access to the Internet. As elites and governments recognize the importance of controlling knowledge and information, so should you be seeking to build on your sources of information.

Decisions do not happen in a vacuum. They are best made when the individual has sufficient information to weigh the possible consequences of various choices. Access to the right information gives decision-making power, builds your range of options from which to make choices, and is a key step toward empowerment and building wealth. Knowledge gives competence and the capacity to act, and sets one on a path of never ending and self-initiated growth.

One of TraderPower.com’s primary goals is to help investors make the right decisions and discover undervalued stocks poised for exceptional profits. For more information, visit www.TraderPower.com.

ENGlobal Corporation (ENG) – Committed to Value

For three decades, ENGlobal has strived to become the preferred supplier of innovative engineering and automation solutions to a string of global clients. The company has aimed high with the intention of becoming the number one provider of novel automation integration services and select engineering, procurement, and construction management projects for the energy industry and other markets around the world.

In the time since its establishment in the 1980s, ENGlobal has become well-known. Today, the company is recognized as a specialty engineering services firm that focuses on serving a variety of markets from alternative energy, pulp and paper and government clients to the upstream, midstream and downstream sectors.

ENGlobal stakes its reputation on the consistent delivery of superior, value-added products and services that meet its commitment to quality. The company also closely follows the ISO-9001 standards that guide its industry to ensure it constantly delivers the best possible value for all stakeholders. Additionally, the team members at ENGlobal hold tightly to quality. It is one of six core values that govern the company’s operations, as seen below:

1. Safety first
2. Communication from the start
3. Teamwork in everything
4. Quality throughout
5. Ethics without exception
6. Total responsiveness

A Houston, Texas-based company, ENGlobal focuses on automation solutions and select engineering, procurement, and construction management projects. The company operates through these two business segments: automation and engineering. The automation segment offers integrated services linked to designing, fabricating and implementing advanced automation, distributed control, instrumentation and process analytical systems – and its solutions fall under two categories: integration and engineering. The EPCM segment provides consulting services for the development, management and execution of projects requiring professional engineering, construction management, and related support services.

For more information, visit www.englobal.com

Location Based Technologies, Inc. (LBAS) Expanding Industry Presence with Innovative Tracking Solutions

Location Based Technologies designs, develops and sells commercial and consumer wearable global positioning system (GPS) tracking solutions based on worldwide GSM networks. The company markets its consumer products under the PocketFinder brand and its commercial products under the LBT brand. Through these two brands, LBAS allows its customers to accurately track and monitor everything from luggage and pets to mobile equipment and vehicles. The company’s products combine the complexities of emerging GPS location devices and wireless technology into simple, easy-to-use location solutions that allow for streamlined user interaction.

The company’s business model includes revenue from both product sales and monthly service payments. In a letter to shareholders in December 2014, Dr. David Morse, chief executive officer of LBAS, highlighted the company’s recent progress in expanding its market presence within this established sales model. Last year, LBAS’s total number of paid monthly users exceeded 72,000, representing an annual increase of more than 120 percent. This growth helped the company achieve positive gross margins for the first time in its history during 2014.

In 2015, LBAS has focused on cutting costs in areas with minimal impact to customers in order to promote sustainable shareholder returns. In addition to enlisting a world class distributor to expand upon its current U.S. sales figures, the company launched a major initiative focused on partnering with auto dealerships throughout the country. This strategy could provide LBAS with a platform to realize improved financial results moving forward. In recent years, the market for vehicles equipped with real-time traffic GPS has continued to expand. According to a report by IBISWorld, annual market growth was recorded at approximately 34 percent over the past five years.

For prospective investors, LBAS’s recent financial growth within the location-based technology industry could foreshadow improved returns in the years to come. Look for the company to promote continued expansion through a combination of enhanced distribution efforts and product innovation within its target markets.

For more information, visit www.pocketfinder.com or www.locationbasedtech.com

Synergy Pharmaceuticals, Inc. (SGYP) Preparing to File New Drug Application for Leading Product Candidate

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) is a biopharmaceutical company focused on the development of novel therapies to treat gastrointestinal diseases and disorders. The company’s product pipeline includes two drug candidates currently being studied in four unique indications. Synergy’s leading candidate, plecanatide, is in late-stage clinical trials for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). Additionally, the company’s next-generation candidate, SP-333, has successfully completed a phase II study in patients with opioid-induced constipation (OIC) and is currently being studied for the treatment of ulcerative colitis (UC).

In recent weeks, Synergy has made noteworthy progress toward the eventual commercialization of plecanatide. Earlier this month, the company announced the initiation of its second phase III clinical trial evaluating the efficacy and safety of the drug candidate in treating IBS-C. Synergy also recently announced positive top-line data results from its first of two phase III trials evaluating the treatment in patients with CIC. According to a report by the National Institute of Health, CIC affects an estimated 14 percent of the global population, demonstrating the immense market potential of plecanatide. Moving forward, these figures could translate into an opportunity for Synergy to experience improved financial results.

“These results strengthen our belief that plecanatide has the potential to not only effectively treat constipation but with a durability and tolerability profile that is ideal for chronic use,” Dr. Gary S. Jacob, chairman and chief executive officer of Synergy, stated in a news release. “We look forward to the results of our second pivotal [CIC] trial in the coming weeks.”

In the first quarter of 2015, Synergy secured the necessary capital to move forward in developing its promising product pipeline. Through a sale of common stock, the company added $5.4 million in net cash to its existing resources. As of March 31, 2015, Synergy’s cash and cash equivalents amounted to approximately $178.6 million, which will allow the company to continue vital clinical testing in the months to come.

“[This] is a pivotal year for Synergy and I am confident we are well-positioned to achieve our clinical objectives,” continued Jacob. “[We] will remain focused on advancing these programs, as well as filing our first NDA (new drug application) with plecanatide for CIC by year-end.”

By providing an effective treatment option for CIC, the company will be able to address an underserved market within the pharmaceutical industry. For prospective investors, Synergy’s rapid approach toward the commercialization of its leading drug candidate could foreshadow an opportunity for favorable returns in the months to come.

For more information, visit www.synergypharma.com

Solitron Devices, Inc. (SODI) Enhancing Shareholder Value alongside Improved Financial Results

Solitron Devices, Inc. (OTCQB: SODI) designs, develops, manufactures and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The majority of the company’s products are custom made pursuant to contracts with clients whose end products are typically sold to the United States government. Solitron also offers a selection of additional products – including joint Army/Navy transistors, diodes and standard military voltage regulators – as standard catalog items.

The company’s firm commitment to quality and excellence has helped it establish a formidable position within the semiconductor equipment industry, particularly as it relates to military and aerospace applications. Solitron’s MIL-PRF-38534 certified and qualified hybrid circuit facility allows for improved access to Department of Defense contracts. Since its founding in 1965, the company has leveraged its strategic industry position to supply its components for use in well over 200 unique programs.

In recent months, Solitron has taken strides toward ensuring maximized shareholder value moving forward. In the quarter ending February 28, 2015, the company recorded a 31 percent increase in gross profit, as compared to the previous quarter. In May, Solitron translated this growth into returns for its investors by declaring a cash dividend of $0.25 per share of common stock. Additionally, the company’s board of directors authorized a repurchase program of up to $500,000 of common stock through February 29, 2016.

“We are continuing to return capital to our stockholders by paying our second cash dividend since emerging from bankruptcy is 1993,” Shevach Saraf, chairman and chief executive officer of Solitron, stated in a news release. “We are committed to enhancing and returning stockholder value. We will continue to regularly review our capital management strategy and evaluate opportunities to return capital to our stockholders.”

In the years to come, Solitron is in a strong position to capitalize on rapid industry growth. According to a report by SEMI, the global industry association serving the manufacturing supply chain for the electronics industries, global semiconductor equipment sales increased by 19.3 percent to $38 billion in 2014 and the market is expected to climb to nearly $44 billion in 2015.

For prospective investors, Solitron’s recent activity could foreshadow an opportunity to realize sustainable returns in the future. Look for the company to capitalize on its momentum in order to increase its market share, particularly in government-related applications.

For more information, visit www.selitrondevices.com

International Stem Cell Corp. (ISCO) Prepares to Begin Clinical Study of Novel Parkinson’s Disease Treatment Option

Imagine a world where there is no donor organ shortage, victims of spinal cord injuries can walk and weakened hearts are successfully replaced; this is the future of regenerative medicine, as outlined by the National Institute of Health. To obtain the massive promises of this revolutionary treatment option, however, it is necessary to successfully overcome the barriers associated with immune response, which have, to this point, severely hampered the advancement of cell replacement therapies. International Stem Cell Corporation (OTCQB: ISCO), through the continued development of its groundbreaking parthenogenesis stem cell technology, is addressing this limitation, potentially unlocking the door to significant advances in the field of regenerative medicine.

Parthenogenesis utilizes unfertilized human eggs to create pluripotent parthogenetic stem cells (hpSC) that can be immune-matched to millions of people. According to the company’s data, a relatively small number of hpSC lines could provide sufficient immune-matched cells to cover a large percentage of the world’s population, effectively minimizing the effects of autoimmune rejection and allowing for continued research into the massive potential upside of stem cell therapy. Unlike embryonic stem cells, which require the destruction of a human embryo, hpSC treatment also avoids many of the ethical issues commonly associated with stem cell research.

ISCO has identified a collection of potential diseases and conditions that could be effectively treated using its hpSCs, but the company’s leading indication is for the treatment of Parkinson’s disease. According to the National Parkinson Foundation, Parkinson’s disease is the 14th leading cause of death in the United States, and an estimated four to six million people suffer from the condition worldwide. Currently, there is no cure and limited treatment options for the disease, creating a significantly underserved market within the pharmaceutical industry.

“In the first quarter of 2015 we completed all the necessary preclinical studies of our Parkinson’s program and formally submitted our application to begin the first clinical study of this novel approach to treating this debilitating disease in humans,” stated Dr. Andrey Semechkin, Chief Executive Officer of ISCO. “We continue to expect to make significant progress during the rest of 2015 towards our goal of providing a viable treatment option for people with Parkinson’s disease.”

During preclinical studies, ISCO has demonstrated the safety and efficacy of treating Parkinson’s disease symptoms in animals with transplanted human parthenogenetic neural stem cells. Moving forward, the company will seek to begin its Phase I/IIa clinical studies through its wholly-owned subsidiary, Cyto Therapeutics Pty Ltd. For prospective shareholders, ISCO’s continued progression with preclinical and clinical studies makes the company an intriguing investment opportunity in the months to come.

For more information, visit www.internationalstemcell.com

Let us hear your thoughts: International Stem Cell Corp. Message Board

Dominovas Energy’s (DNRG) Trail Leads to Partnership with U.S. Government

Dominovas Energy’s stock had an impressive run earlier this week after the fuel cell technology company announced a “historic” partnership with the U.S. Government. Shares soared nearly 3000% on the news, hitting an intra-week high of $0.33; the stock trades in a 52-week range of $0.0035-$0.60. A federal partnership is obviously a big deal and warrants a look at how this micro-cap company got its name on the books.

More than ever before, consumers are spending their money on “green” alternatives, tuning into global concerns about climate change, energy security, and air pollution. Dominovas Energy looks at these issues on a global scale, as it seeks to implement its fuel cell technology in emerging countries, where reliable electricity is intermittent, scarce, or non-existent.

Focusing on this global concern, Dominovas Energy is committed to creating a virtually silent solution with near-zero NOX emissions and minimal carbon footprint, all while producing reliable and clean energy for local communities, industry, and nations. To this accord, Dominovas Energy is championing its RUBICON™ Solid Oxide Fuel Cell (SOFC) system as a leading, viable, global energy solution.

Fuel cell power generation is an efficient, combustion-less, reliable and virtually pollution-free emitting device that provides electricity to power a wide array of applications, ranging from buildings, primary power for grid integration, automobiles, emergency back-up systems, and base load grid power. By electrochemically combining oxygen with hydrogen extracted from a hydrocarbon-based fuel supply to produce electricity, emitting only water, minimal pollution, and excess heat as by-products, fuel cells function much like a battery, but without the need for recharging. Fuel cells produce electricity as long as there is a constant fuel source and are rapidly gaining traction as an ideal solution for a variety of portable, on-board, and stationary electric power generation applications.

Dominovas Energy has identified marketing and sales opportunities for fuel cells in emerging-market countries, where electricity supply is frequently unreliable, antiquated, and expensive compared to the cost of electricity and the production, as found in the United States. Consequently, the Company’s primary focus at this time is on Africa, where it has established active projects and works with each nation’s government. And further with the support of Delphi Automotive Systems to jointly develop the technology and methodologies necessary to facilitate the commercial nature, manufacture, assembly, and deployment of the RUBICON™ system, this partnership fully supports Dominovas Energy’s continued deployment of clean energy solutions on a multi-megawatt (MW) scale.

As detailed in an historic announcement in June, Dominovas Energy was accepted as a private sector partner of the “Power Africa Initiative” launched by President Barack Obama in June 2013. A multi-year guaranteed power provider agreement (PPA) announced earlier this month shows how Dominovas Energy jumped into action in Africa.

At the beginning of June, Dominovas Energy reported that it signed a 3MW PPA to utilize the RUBICON™ system to provide clean electricity to the City of David in the Democratic Republic of the Congo (DRC). Expected to be “the first of many efforts the governor of the State of Katanga in the Democratic Republic of Congo is pursuing across his state to increase the availability of affordable housing and social facilities,” the Project will represent the largest single deployment of fuel cell technology on the continent of Africa.

Slated for the fourth quarter of 2016, the physical deployment of the RUBICON™ will trigger the annual production of more than 25.5 million kWh of clean, efficient and reliable electricity and will yield more than US$100 million in guaranteed revenue to Dominovas Energy over the course of the agreement.

A week after the City of David announcement, Dominovas Energy signed another 3MW multi-year PPA. This time the agreement concerned Dominovas providing electricity to the privately held Somico Mine in the DRC. Somico has several mining operations in the DRC; and with the vast reserves of natural resources in Africa, the mining sector represents a tremendous opportunity for Dominovas Energy’s continued expansion across diverse applications of the RUBICON™. The mining sector in Africa singularly represents a multibillion dollar industry, and offers Dominovas Energy the potential to deploy more than 250 MW of power to mining operations and their communities.

Now fast-forward to date – and take a look at how Dominovas Energy pivoted from the PPAs to its deal with the U.S. government.

By deploying its RUBICON™ systems, Dominovas Energy is the first-and-only fuel cell company selected as a private sector partner to the Power Africa Initiative, which is comprised of private sector participants, the United States government and governments of several African countries. These partners represent the foundation for building the regulatory, economic, and policy framework needed to meet Africa’s increasing demand for, and access to, electricity.

As a Power Africa member company, Dominovas Energy will benefit from interagency efforts, leveraging Power Africa’s tools such as technical expertise and financing. Dominovas said that over the next several years, it intends to support and advance Power Africa goals by providing access to clean, reliable energy; partnering with specific universities in Africa to train and hire local citizens as engineers and technicians, as necessary for the installation, service, and ongoing maintenance of the RUBICON™; and providing Power Africa countries with access to distributed, off-grid electricity on a multi-megawatt scale.

According to the Company’s news release, deployments of the RUBICON™ are expected to increase the quantity of power available to over 100 million people by 2021, directly benefitting citizens, households, and businesses by producing clean, reliable and continuous energy.

When you look at the broader Dominovas Energy picture, take into consideration that financials are not typically stellar at the sub-penny level DNRG was trading at last week; but deals like the ones mentioned above, solid operations, and a powerful management team are what give small companies a tangible base from which to realize its strong potential and validate its place on the map.

Neal Allen is chairman, president and CEO of Dominovas Energy. He previously served in the same capacity with Dominovas Energy, LLC. Prior to Dominovas Energy, LLC he served as the Principal Shareholder of a private Family Office, which specialized in the development and implementation of proprietary revenue models as a force multiplier ensuring optimal deployment, utilization, and management of financial resources. Under Allen’s watch, the Family Office’s endeavors included the ownership of a “major brand” automobile dealership, several healthcare companies, waste management and disposal enterprises, land acquisition and development, and natural resource development enterprises.

Allen is joined by Emilio De Jesus, board member and president of the Africa Division for Dominovas, where he is integral in assisting in the creating of strategies that best bring to fruition the deployment of the RUBICON™ to emerging markets in Africa.

De Jesus specializes in intelligence pertaining to each country’s barriers of entry, political climate and most suitable partners. As the Country Advisor, De Jesus visits potential countries to research their state of the energy production industry, interview potential partners, and meet with political officials. He also negotiates favorable PPAs, liaising with local partners, as well as with potential “Off Takers.”

De Jesus, for over 15 years, previously managed telecommunications projects for a fortune 500 company, and has gained extensive experience in the deployment of new technologies within Continental USA.

Piece by piece, the Dominovas Energy story makes sense – portraying the Company’s momentum as it achieves its commitment to emerging markets and solidifies its position in the United States as a viable ally to Africa and its long-term power needs. The Company has a keen ability to recognize and take advantage of the incredible growth and profit opportunities of the green and alternative energy markets, advancing the deployment of its green energy solutions where it matters most.

For more information visit www.dominovasenergy.com

Let us hear your thoughts: Dominovas Energy Corp. Message Boards

From Our Blog

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Year-End Report Shows Alignment with Domestic Resource Priorities, Strong Strategic Positioning

March 4, 2026

Disseminated on behalf of Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) and may include paid advertising. As governments worldwide focus on strengthening supply chains for strategic resources, domestic production of critical minerals has emerged as a central pillar of industrial policy. In the United States, concerns about reliance on foreign sources for metals essential […]

Rotate your device 90° to view site.